Silo Pharma, Inc. Annual Deferred Income Tax Expense (Benefit) in USD from 2020 to 2021
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Silo Pharma, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from 2020 to 2021.
- Silo Pharma, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2022 was $0.000, a 100% decline year-over-year.
- Silo Pharma, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was $24.9K.
Deferred Income Tax Expense (Benefit), Annual (USD)